Long-Term Safety and Effectiveness of Adalimumab in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis.

被引:0
|
作者
Brunner, Hermine [1 ]
Ruperto, Nicola [2 ]
Wallace, Carol A. [3 ,4 ]
Toth, Mary [5 ]
Foeldvari, Ivan [6 ]
Bohnsack, John [7 ]
Milojevic, Diana [8 ]
Rabinovich, C. Egla [9 ]
Vavrincova, Pavla [10 ]
Kingsbury, Daniel J. [11 ]
Marzan, Katherine [12 ]
Quartier, Pierre [13 ]
Minden, Kirsten [14 ]
Chalom, Elizabeth [1 ]
Horneff, Gerd [15 ]
Kuester, Rolf M. [16 ]
Dare, Jason [17 ]
Bereswill, Mareike [18 ]
Kupper, Hartmut [18 ]
Kalabic, Jasmina [18 ]
Lovell, Daniel [19 ]
Martini, Alberto [20 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, PRCSG, Cincinnati, OH 45229 USA
[2] PRINTO, Genoa, Italy
[3] Univ Washington, Sch Med, Seattle, WA USA
[4] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA
[5] Akron Childrens Hosp, Akron, OH USA
[6] Hamburger Zentrum Kinder & Jugendrheumatol, Dept Pediat Rheumatol, Hamburg, Germany
[7] Univ Utah, Dept Pediat, Salt Lake City, UT USA
[8] Tufts Med Ctr, Floating Hosp Children, Boston, MA USA
[9] Duke Univ, Med Ctr, Durham, NC USA
[10] Fak Nemocnice Motole, Prague, Czech Republic
[11] Randall Childrens Hosp Legacy Emanuel, Portland, OR USA
[12] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[13] Univ Paris 05, Hop Necker Enfants Malad, AP HP, IMAGINE Inst, Paris, France
[14] Kinderklin Charite, Otto Heubner Ctr, Berlin, Germany
[15] Asklepios Klin Sankt Augustin, St Augustin, Germany
[16] Asklepios Rheumazentrum Hamburg, Hamburg, Germany
[17] Arkansas Childrens Hosp, Little Rock, AR 72202 USA
[18] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
[19] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH USA
[20] PRINTO IRCCS, Genoa, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
273
引用
收藏
页码:S115 / S116
页数:2
相关论文
共 50 条
  • [21] Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
    Kingsbury, Daniel J.
    Bader-Meunier, Brigitte
    Patel, Gina
    Arora, Vipin
    Kalabic, Jasmina
    Kupper, Hartmut
    CLINICAL RHEUMATOLOGY, 2014, 33 (10) : 1433 - 1441
  • [22] Safety, effectiveness, and pharmacokinetics of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to 4 years
    Daniel J. Kingsbury
    Brigitte Bader-Meunier
    Gina Patel
    Vipin Arora
    Jasmina Kalabic
    Hartmut Kupper
    Clinical Rheumatology, 2014, 33 : 1433 - 1441
  • [23] Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate
    Lovell, Daniel J.
    Brunner, Hermine, I
    Reiff, Andreas O.
    Jung, Lawrence
    Jarosova, Katerina
    Nemcova, Dana
    Mouy, Richard
    Sandborg, Christy
    Bohnsack, John F.
    Elewaut, Dirk
    Gabriel, Christos
    Higgins, Gloria
    Kone-Paut, Isabelle
    Jones, Olcay Y.
    Vargova, Veronika
    Chalom, Elizabeth
    Wouters, Carine
    Lagunes, Ivan
    Song, Yanna
    Martini, Alberto
    Ruperto, Nicolino
    RMD OPEN, 2020, 6 (02):
  • [24] The long-term safety of etanercept in children with polyarticular or systemic juvenile rheumatoid arthritis
    Giannini, E. H.
    Llowite, N. T.
    Lovell, D. J.
    Wallace, C. A.
    Rabinovich, C. E.
    Reiff, A. O.
    Higgins, G.
    Chon, Y.
    Lin, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 550 - 550
  • [25] Safety of Adalimumab±Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
    Brunner, Hermine I.
    Ruperto, Nicola
    Nanda, Kabita
    Toth, Mary
    Foeldvari, Ivan
    Bohnsack, John F.
    Milojevic, Diana
    Rabinovich, C. Egla
    Kingsbury, Daniel J.
    Marzan, Katherine
    Quartier, Pierre
    Minden, Kirsten
    Chalom, Elizabeth
    Horneff, Gerd
    Kuester, Rolf M.
    Dare, Jason A.
    Bereswill, Mareike
    Kalabic, Jasmina
    Kupper, Hartmut
    Lovell, Daniel J.
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] LONG-TERM SAFETY OF SUBCUTANEOUS TOCILIZUMAB ADMINISTRATION IN SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Ramanan, Athimalaipet
    Cuttica, Ruben
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir, Maria Luz Gamir
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Mallalieu, Navita L.
    Martini, Alberto
    Lovell, Daniel J.
    Brunner, Hermine
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 548 - 548
  • [27] Long-Term Safety of Subcutaneous Tocilizumab Administration in Systemic and Polyarticular Juvenile Idiopathic Arthritis
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Ramanan, Athimalaipet V.
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Luz Gamir-Gamir, Maria
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [28] EFFICACY AND SAFETY OF TOCILIZUMAB IN POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS: 2 YEAR DATA FROM CHERISH
    Baildam, Eileen
    Ramanan, Athimalaipet
    Woo, Patricia
    Brunner, Hermine
    Ruperto, Nicola
    Zuber, Zbyszek
    Cuttica, Ruben J.
    Xavier, Ricardo
    Penades, Inmaculada Calvo
    Rubio-Perez, Nadina
    Alexeeva, Ekaterina
    Chasnyk, Vyacheslav
    Chavez, Jose
    Horneff, Gerd
    Opoka-Winiarska, Violetta
    Quartier, Pierre
    Spindler, Alberto
    Keane, Caroline
    Bharucha, Kamal
    Wang, Jianmei
    Lovell, Daniel J.
    Martini, Alberto
    De Benedetti, Fabrizio
    RHEUMATOLOGY, 2014, 53 : 52 - 53
  • [29] SAFETY AND EFFECTIVENESS OF ADALIMUMAB±METHOTREXATE FOR THE TREATMENT OF POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS (PJIA): STRIVE REGISTRY
    Ruperto, N.
    Lovell, D. J.
    Wallace, C.
    Toth, M.
    Foeldvari, I.
    Bohnsack, J.
    Milojevic, D.
    Rabinovich, E.
    Kingsbury, D.
    Marzan, K.
    Quartier, P.
    Minden, K.
    Chalom, E.
    Horneff, G.
    Kuester, R. M.
    Dare, J.
    Heinrich, M.
    Kupper, H.
    Kalabic, J.
    Martini, A.
    Brunner, H. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 266 - 266
  • [30] IDENTIFICATION OF OPTIMAL SUBCUTANEOUS (SC) DOSES OF TOCILIZUMAB IN CHILDREN WITH POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS (PCJIA)
    De Benedetti, F.
    Ruperto, N.
    Lovell, D.
    Ramanan, A. V.
    Cuttica, R.
    Weiss, J. E.
    Henrickson, M.
    Schmeling, H.
    Anton, J.
    Minden, K.
    Hsu, J.
    Bharucha, K.
    Wimalasundera, S.
    Kadva, A. K.
    Upmanyu, R.
    Mallalieu, N. L.
    Martini, A.
    Brunner, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 396 - 396